Quantcast
Last updated on April 18, 2014 at 14:49 EDT

Latest Lesion Stories

2008-08-04 09:01:04

Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced that patient accrual in the MelaFind(R) pivotal trial was completed last week. MelaFind is a non-invasive, point-of-care instrument designed and developed by EOS to assist in the early diagnosis of melanoma, the deadliest form of skin cancer. "This represents a significant milestone for the company in our quest to improve early melanoma detection," said Joseph V. Gulfo, MD, MBA, President & CEO. "We would like to...

2005-07-01 16:15:00

New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system. For decades, scientists have known that HPV causes nearly all cases of cancer in the neck of the womb. Most sexually active women "“ some...